Company profile · Biotech & medical
華安醫學股份有限公司 · 6657
Drafted and translated from cited sources, with links to the passages they are based on for your verification. Care is taken to translate its original meaning from Mandarin as closely as possible.
Energenesis Biomedical develops new drugs using its proprietary ENERGI drug development platform to activate AMP-activated protein kinase, a key enzyme in cellular energy regulation, as a method for disease treatment.[1]
The company focuses on biomedical intellectual property development, utilizing internally researched and developed new drug technologies and patents, with a business model centered on technology licensing to domestic and international pharmaceutical companies following clinical trial validation.[2]
Its development pipeline includes new drug candidates such as ENERGI-F703EB cream for epidermolysis bullosa, and treatments for diabetic foot ulcers.[3]
Based in Taipei, Taiwan, the company was established in 2012 and qualified as a biotech new drug company by the Ministry of Economic Affairs in 2015.[1]
| Latest month | Revenue | Year on year | Month on month |
|---|---|---|---|
| 2026-10 | NT$0m | -66.1% | -11.1% |
2024-11 to 2026-10, monthly revenue.
| Last 20 trading days | Net |
|---|---|
| 2026-10-12 to 2026-11-10 | −NT$3m |
Net buying (green) and selling (red) by foreign investors, NT$ at each day's close. All companies.
| Full English name | Energenesis Biomedical CO.,LTD. |
|---|---|
| Chinese name | 華安醫學股份有限公司 |
| Stock code | 6657 (TWSE) |
| Industry | Biotech & medical |
| Founded | 28 Aug 2012 |
| Listed | 12 Jun 2023 |
| Paid-in capital | NT$897m |
| Chairman | 陳翰民 |
| President | 江銘燦 |
| Headquarters | 6F.-3, No.21, Ln.583, Ruiguang Rd., Neihu Dist., Taipei 11492, Taiwan |
| Website | http://www.energenesis-biomedical.com |
| Official business description | 新藥開發 · 檢測分析服務及試劑銷售 |
Facts from MOPS company basic information, retrieved 03 Nov 2026. The official business description is the company's own entry and can be out of date.
Generated 2026-11-11 00:39.